JEEP isn't only endo concern. ERP would like a word.....

Status
Not open for further replies.

oldrunnerguy

GLP-1 Apprentice
Member Since
Feb 2, 2026
Posts
90
Likes Received
381
Location
USA
I hope it's OK to post the link. Here's another argument for testing your peps and the lousy response from ERP.

https://krуsia0430.suspicious-link-removed.com/p/the-trouble-with-erp
 
oldrunnerguy said:
I hope it's OK to post the link. Here's another argument for testing your peps and the lousy response from ERP.

https://krуsia0430.suspicious-link-removed.com/p/the-trouble-with-erp

Link doesn't seem to be working.

attachments-1776615196895-webp.20495.webp


attachments-1776615212260-webp.20496.webp
 

Attachments

  • attachments-1776615196895-webp.20495.webp
    attachments-1776615196895-webp.20495.webp
    37.1 KB · Views: 1
  • attachments-1776615212260-webp.20496.webp
    attachments-1776615212260-webp.20496.webp
    28.4 KB · Views: 1
Any chance of posting the issue, without links to third party sites?
 
Ryanking11 said:
Any chance of posting the issue, without links to third party sites?
https://krуsia0430.suspicious-link-removed.com/p/the-trouble-with-erp. Dang, I hope this works
 
https://krуsia0430.suspicious-link-...rp?r=1d5ydq&utm_medium=ios&triedRedirect=true
 
Ryanking11 said:
Any chance of posting the issue, without links to third party sites?
It's an depth article listing out multiple problems with the vendor ERP. Reading it on suspicious-link-removed would be recommended.
 
Oh, this is interesting. The lying machine says the 'y' is different. Anyway, if you Google "the Trouble with ERP some lady & her AI ghostwriter," it's the first result.

Edit: lulz, and the filters are catching me on the name, I give up.
 
"This started with a customer-led group test involving roughly 80–85 people . Participants bought ERP products themselves, pooled samples, voted on which peptides to send, and organised independent Janoshik testing under the deliberately neutral label “Strong Like Bull” (SLB) so the COAs could not easily be reused by ERP for marketing.

Around 12 ERP peptides were tested and although most products came back acceptable on purity, one product stood out: SS31 50mg . That result showed 44.10 mg , which is about 11.8% underfilled , and also raised an endotoxin concern ."

Google ("the trouble with ERP" some lady & her AI ghostwriter) and it should show up

https://substackcdn.com/image/fetch/$s_!mH3w!,f_auto,q_auto:good,fl_progressive:steep/https://suspicious-link-removed-post-media.s3.amazonaws.com/public/images/16d24641-e1b6-4084-8460-3a4357874028_1062x385.jpeg

K_R_Y_S_I_A
 
Romulusguy said:
Still not working. Could you please screen shot and paste here or summarize the issue for us here?
It's not just one issue. It's a long article.
 
For quality issues, even Uther has been sucking for some things lately regarding purity and endotoxins, with a record amount of endotoxins for NAD+. Uther had ARA-290 at 86% purity. Low purity for SNAP-8 as well (94%). But Uther has been pretty transparent.

It reminds of the zero peptides situation around December 2024 (before my time) where multiple vendors were affected. More recently, the cloudy reta this year from multiple vendors, possibly due to TFA salts (not just vendor BAC).

SRY had a number of quality concerns last spring/summer, like little black specks in vials. Nexaph had a similar issue with the black specks last May.
 
AI Summary of this issue:

TLDR: A community group test caught ERP's SS31 underfilled by ~12% and flagged for high endotoxins. Instead of refunding affected buyers, ERP offered vague future-order credits, dodged accountability with shifting technical explanations, and reportedly banned customers and deleted chat history when they pushed back. Digging deeper revealed a broader pattern: cloudy products, shipping fees added after purchase, discounts pulled back after orders were placed, and policies changed retroactively to minimize refunds. The article argues the gap between ERP's marketing promises and actual customer experience is substantial and consistent.

Summary: "The Trouble with ERP" (some lady & her AI ghostwriter, April 19, 2026)

A community-organized group test involving roughly 80-85 participants exposed a cascade of product, policy, and customer service problems at peptide vendor ERP. Here are the key issues raised:

The Triggering Event: SS31 Testing

An independent third-party Janoshik test of ERP's SS31 50mg vials showed only 44.10mg actual content, roughly 11.8% underfilled. More seriously, the vials also returned endotoxin levels above the assay's validated reporting range, with an estimated value of 26.790 EU/vial. The group used a neutral label ("Strong Like Bull") on samples specifically to prevent ERP from co-opting the COAs for marketing.

ERP's Response Pattern to the SS31 Result

Rather than offering a straightforward refund or replacement, ERP responded with a series of shifting explanations:

Overfill claims (products are supposedly filled at 1.25x), suggesting low test results reflect product characteristics rather than true underfill

Suggestions that high content causes poor dissolution, making test results unreliable

Exclusion of endotoxin from warranty coverage entirely, citing cost and potential impact on peptide activity as justification for not meeting stricter standards

Resolution offered was only a vague, undefined future-order credit, not a refund

One buyer who pressed for a full refund was met with a laughing emoji in response. When they escalated to chargeback threats, they were reportedly banned and their chat messages deleted.

Broader Product Issues

SLU-PP-332 : Reported as cloudy on reconstitution. ERP first blamed the buyer's BAC water, then reversed to claim the product is naturally turbid. The real issue, not disclosed upfront, is that SLU-PP-332 likely requires DMSO-based solvent to dissolve properly, making it unsuitable for general use without specific guidance.

MOTS-c : Reconstituted clear, but turned cloudy after 24 hours refrigerated, suggesting post-reconstitution instability.

Other buyers reported additional undisclosed or unresolved cloudy product issues.

Shipping and Pricing Policy Complaints

Multiple buyers described terms changing after orders were already placed or in motion:

A Canada-bound buyer was switched from FedEx to Canada Post after the order was placed; the shipping cost difference was only offered as a future-order credit.

A buyer qualifying for free shipping was later told their location was a "remote area" and hit with an unexpected $85+ surcharge after the order was underway.

A large-order buyer was promised a 4% discount, which was quietly revised down to 3% after committing.

A seized order buyer was originally promised full refund or reshipment, then retroactively told a policy change required either 50% payment to reship or a 30% refund.

The "Rolling Problems Forward" Pattern

Several buyers described a recurring dynamic where unresolved issues from one order were acknowledged but not actually fixed, only folded into the next purchase as partial credit or conditional resolution, incentivizing repeat orders rather than clean refunds.

Attribution Deflection

Once the SS31 evidence was presented publicly, ERP shifted to questioning whether the tested product could even be attributed to them, pointing to the neutral SLB label, absence of ERP branding on the COA, and alleged cap color discrepancies as grounds for doubt.

Chat Moderation and Narrative Control

The article claims that shortly after a public warning summarizing the issues was posted, bot accounts appeared in the relevant chat to flood and bury the complaints. It also alleges ERP has deleted negative COAs and banned customers who pushed for refunds, with at least one confirmed case where a buyer was banned and chat history removed after escalating to a chargeback threat.

The Gap Between Marketing and Reality

ERP's stated promises include: a dedicated quality inspection department, products only sold after passing QC, full refunds available for purity/quality failures, lab-tested products, and a stocked U.S. warehouse. The article argues the documented experiences systematically contradict each of those claims.

Bottom Line

The article frames SS31 as the crack that opened a much broader picture: a vendor pattern of shifting explanations, post-sale policy changes, refusal to issue clean refunds, and active suppression of public complaints. The "best" outcome any affected buyer received was a 20% future-order credit, which the author wryly notes made that buyer "the lucky one."
 
Interesting. I was looking at them for T30, but the cap color concerned me. They assured they have their own factory. I didn’t order. Glad I didn’t.
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,620
Messages
55,146
Members
1
Latest member
Admin
Back
Top